Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia

  • Sze May Ng*
  • , Karolina Stepien
  • *Corresponding author for this work

Research output: Contribution to journalArticle (journal)peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare and determine the efficacy and safety of different glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency CAH in children and adults.

Original languageEnglish
Article numberCD012517
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number1
DOIs
Publication statusPublished - 18 Jan 2017

Fingerprint

Dive into the research topics of 'Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia'. Together they form a unique fingerprint.

Cite this